10 years ago, St. Jude took on pediatric cancer genome, and won
Dr. James Downing, president and CEO of St. Jude Children’s Research Hospital, has been instrumental in the development and refinement of St. Jude’s genomic sequencing operations for pediatric cancer. (Patrick Lantrip/Daily Memphian)
Topics
Dr. James Downing St. Jude Children’s Research Hospital Pediatric Cancer Genome Project
Jane Roberts
Longtime journalist Jane Roberts is a Minnesotan by birth and a Memphian by choice. She's lived and reported in the city more than two decades. She covers healthcare and higher education for The Daily Memphian.